Lu K Wang

7393522, Jul 1, 2008

Sep 3, 2003

10/655493

Ramin Najafi - Novato CA, US
Lu Wang - Emeryville CA, US
Mansour Bassiri - Davis CA, US
Jane Yang - Emeryville CA, US

NovaBay Pharmaceuticals, Inc. - Emeryville CA

A61K 31/74
A61K 33/40
A61K 33/14

424 7804, 424 7806, 424 7807, 424613, 424661

Described herein is a physiologically-balanced, acidic solution. Typically the solution is prepared by a chemical reactions or by the electrolysis of a solution comprising a mixture of an inorganic salt to form a physiologically balanced solution. This invention also relates to methods for use of the solutions, including a specialized bandage which may be used in combination with the solutions, or optionally with other topically applied materials. A mixture of inorganic salts and, optionally minerals, is used in order to mimic the electrolyte concentration and mixture of body fluid in an isotonic state. The solution typically comprises of one halide salt of lithium, sodium, potassium, calcium, and other cations. Typically the halide is fluoride, chloride, bromide, or iodide, and most typically chloride. A typical electrolyzed solution of the present invention has a pH within the range of about 2 to about 5, an oxidation reduction potential within the range of about +600 mV to about +1200 mV, and hypohalous acid concentration in the range of about 10 ppm to about 200 ppm.

7846971, Dec 7, 2010

Jan 25, 2006

11/339987

Ramin Najafi - Novato CA, US
Mansour Bassiri - Albany CA, US
Lu Wang - Moraga CA, US
Behzad Khosrovi - El Cerrito CA, US

Novabay Pharmaceuticals, Inc. - Emeryville CA

A61K 31/13
C07C 309/18
C07C 309/13
C07C 309/14

514612, 562104, 562105

The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds. FIG. : A dual chamber apparatus for the preparation of NNDCT on site.

7893109, Feb 22, 2011

Sep 11, 2008

12/209002

Mansour Bassiri - Novato CA, US
Ramin Najafi - Novato CA, US
Lu Wang - Moraga CA, US
Jane Yang - Emeryville CA, US

Novabay Pharmaceuticals, Inc. - Emeryville CA

A61K 31/13
A61K 31/66
C07C 309/03

514612, 514578, 562104, 562105

The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.

20070244449, Oct 18, 2007

Oct 5, 2006

11/544180

Ramin Najafi - Novato CA, US
Mansour Bassiri - Novato CA, US
Lu Wang - Moraga CA, US
Behzad Khosrovi - El Cerrito CA, US

A61M 25/00
A61K 33/20

604265000, 424661000, 424723000

Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter-Associated Urinary Tract Infections (CAUTI). The system comprises a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and/or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the bladder, or irrigating the bladder with the composition.

20080279963, Nov 13, 2008

Mar 21, 2008

12/053536

Ramin Najafi - Novato CA, US
Lu Wang - Emeryville CA, US
Mansour Bassiri - Emeryville CA, US
Jane Yang - Emeryville CA, US

A61K 33/14
A61P 17/02

424661

Described herein is a physiologically-balanced, acidic solution. Typically the solution is prepared by a chemical reactions or by the electrolysis of a solution comprising a mixture of an inorganic salt to form a physiologically balanced solution. This invention also relates to methods for use of the solutions, including a specialized bandage which may be used in combination with the solutions, or optionally with other topically applied materials. A mixture of inorganic salts and, optionally minerals, is used in order to mimic the electrolyte concentration and mixture of body fluid in an isotonic state. The solution typically comprises of one halide salt of lithium, sodium, potassium, calcium, and other cations. Typically the halide is fluoride, chloride, bromide, or iodide, and most typically chloride. A typical electrolyzed solution of the present invention has a pH within the range of about 2 to about 5, an oxidation reduction potential within the range of about +600 mV to about +1200 mV, and hypohalous acid concentration in the range of about 10 ppm to about 200 ppm. The solution has bactericidal, fungicidal, and sporicidal properties. The composition of the invention is nontoxic and has antibacterial properties, and is useful in any application in which antimicrobial properties are desirable.

20090221989, Sep 3, 2009

Sep 21, 2006

12/067452

Ramin Najafi - Novato CA, US
Mansour Bassiri - Novato CA, US
Lu Wang - Moraga CA, US
Behzad Khosrovi - El Cerrito CA, US

A61L 29/16
A61M 25/00
A61B 19/02
A61L 2/18
A61K 33/14
A61K 33/06
A61K 33/00
A61P 31/00

604517, 604265, 206364, 422 37, 424680, 424679, 424681, 424682, 424722

Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter-Associated Urinary Tract Infections (CAUTI). The system comprises of a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and/or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the bladder, or irrigating the bladder with the composition.

20100010456, Jan 14, 2010

Sep 18, 2009

12/562982

Ramin Najafi - Novato CA, US
Mansour Bassiri - Novato CA, US
Lu Wang - Moraga CA, US
Behzad Khosrovi - El Cerrito CA, US

A61L 29/16

604265

Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter-Associated Urinary Tract Infections (CAUTI). The system comprises a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and/or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the bladder, or irrigating the bladder with the composition.

20100272783, Oct 28, 2010

Apr 23, 2010

12/766673

Lu Wang - Emeryville CA, US
Bahram Memarzadeh - San Carlos CA, US

A61K 9/70
A61K 31/185
A61P 17/00
A61P 43/00

424447, 514578

Disclosed herein are compositions and methods of treating or preventing an infection of the nail, claw, or hoof comprising administering to a subject a pharmaceutical composition comprising an N-halogenated or N,N-dihalogenated amine compound of the application.